Endometrial Cancer in Hospital Universiti Sains Malaysia |
Wan-Nor-Asyikeen, Wan Adnan
(Unit of Biostatistics and Research Methodology)
Siti-Azrin, Ab Hamid (Unit of Biostatistics and Research Methodology) Jalil, Nur Asyilla Che (Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia) Othman, Nor Hayati (Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia) Zain, Anani Aila Mat (Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia) |
1 | Kashima H, Shiozawa T, Miyamoto T, et al (2009). Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogenactivated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer, 16, 113-22. |
2 | Kaupilla A, Gronroos M, Nieminen U (1982). Clinical outcome in endometrial cancer. Obstet Gynecol, 60, 473-80. |
3 | Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2008). Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer, 98, 1582-85. DOI |
4 | Lopez-Bermejo A, Khosravi J, Fernandez-Real JM, et al (2006). Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes, 55, 2333-39. DOI |
5 | Mannelqvist M, Sefanson IM, Bredholt G, et al (2011). Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer. Am J Pathol, 178, 861-71. DOI |
6 | Mendivil A, Schuler KM, Gehrig PA (2009). Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control, 16, 46-52. DOI |
7 | Pavelic J, Radakovic B, Pavelic K (2007). Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Gynecol Oncol, 105, 727-35. DOI |
8 | Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53. DOI |
9 | Schonfeld SJ, Hartge P, Pfeiffer RM, et al (2013). An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer, 119, 1393-99. DOI |
10 | Baird D, Dunson DB (2003). Why is parity protective for uterine fibroids? Epidemiol, 14, 247-50. |
11 | Briet JM, Hollema H, Reesink N, et al (2005). Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol, 96, 799-4. DOI |
12 | Brinton LA, Westwoff CL, Scoccia B, et al (2013). Fertility drugs and endometrial cancer risk: results from an extended followup of a large infertility cohort. Hum Reprod, 28, 2813-21. DOI |
13 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-17. DOI |
14 | Yu H & Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472-89. DOI |
15 | Zainal Ariffin O, Nor Saleha I (2011). National Cancer Registry Report 2007. Malaysia: Ministry of Health. |
16 | Zaorsky NG, Patil N, Freedman GM, Tuluc M (2012). Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis. J Breast Cancer, 15, 478-80. DOI |
17 | Dos Reis R, Burzawa JK, Tsunoda AT, et al (2015). Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer. Int J Gynecol Cancer, 25, 1292-99. DOI |
18 | Dossus L, Allen N, Kaaks R, et al (2010). Reproductive risk factors and endometrial cancer: The European Prospective Investigation into Cancer and Nutrition. Int J Gynecol Cancer, 127, 442-51. |
19 | Emons G, Fleckensteins G, Hinney B, Huschmand A, Heyl W (2000). Hormonal interactions in endometrial cancer. Endocr Relat Cancer, 7, 227-42. DOI |
20 | Fauziah M, Hamizah M, Norazmi A, Lila P (2006). Report no. 1/2006. Kota Bharu: Kelantan Health State Department, 1999-2003. |
21 | Friberg E, Mantzoros CS, Wolk A (2007). Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev, 16, 276-80. DOI |
22 | Henderson BE, Feigelson HS (2000). Hormonal carcinogenesis. Carcinogenesis, 21, 427-33. DOI |
23 | Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011). Global cancer statistics. CA Cancer J Clin, 69, 69-90. |
24 | Jones ME, Van Leeuwen FE, Hoogendoorn WE, et al (2012). Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast Cancer Res, 14, 91. DOI |
25 | Karageorgi S, Hankinson SE, Kraft P, De Vivo I (2010). Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer, 126, 208-16. DOI |